Rep. Matt Gaetz, Trump Ally, Sponsors Medical Pot Bill
*By Jacqueline Corba*
Freshman Congressman Matt Gaetz (R-FL) is on a mission to pass a bill that would allow for expanded medical marijuana research.
"Research can demystify who is right and who is wrong," Gaetz told Cheddar's CannaBiz Tuesday. "It's kind of nice to let the science guide our policy making."
Last week, the [Medical Marijuana Act](https://gaetz.house.gov/media/press-releases/congressman-matt-gaetz-applauds-passage-medical-cannabis-bill-through-house) sponsored by Gaetz passed the U.S. House Judicial Committee with bipartisan support.
It's a "landmark moment" Gaetz said; it's the first time Republicans in control of Congress have passed a medical marijuana bill through committee. Next it will head to the House floor for a vote.
"I'm super excited about what potential cannabis has in healthcare, and I think we'll learn a lot more if we're not so stupid as a government to make the research illegal," Gaetz said.
The act would give research institutions "safe harbor" to study the potential uses, benefits, and risks of the drug, which remains a Schedule I classification under the federal law alongside heroin and LSD.
"I think that marijuana policy has in many ways been victimized by the overall chilled relationship between the White House and the Department of Justice," Gaetz said.
"I think it is really Jeff Sessions who opposes medical marijuana, and I'm not entirely sure he and President Trump will be on one another's Christmas lists going forward."
For Gaetz, Washington is obstructing its own view.
"Washington just needs to get out of the way so that we can really see the potential."
For full interview [click here](https://cheddar.com/videos/medical-cannabis-research-act-passes-first-hurdle-in-congress).
Catching you up on the stories you need to know this morning, the U.S. could soon get its first major gun safety law in years, the House Select Committee investigating the January 6th attack on the U.S. capitol holds its second hearing, and today might just be the day the Supreme Court overturns Roe v. Wade, and decides on new gun laws.
U.S. stocks closed Thursday at their lowest levels of the trading day, as investors continue to eye inflation ahead of the May CPI report out Friday. Art Hogan, Chief Market Strategist for National Holdings, joins Cheddar News' Closing Bell to discuss.
The PGA has suspended 17 golfers, including Phil Mickelson and Dustin Johnson, who are competing in a Saudi-backed golf event outside of London. In a memo, commissioner Jay Monahan said "these players have made their choice for their own financial-based reasons", announcing they are ineligible to participate on the PGA tour or any other tours it sanctions. Hugh Kellenberger, Senior Managing Editor at the Athletic, breaks down the controversy, and what might happen next.
U.S. stocks closed Friday at session lows after May CPI data showed inflation in the U.S. has not peaked and is still rising rapidly. For the week, the S&P fell 5.06%, the Dow lost 4.58%, and the Nasdaq dropped 5.60%, marking the worst week since January for all three major indexes. Mike Zigmont, Head of Trading and Research at Harvest Volatility Management, joins Cheddar News' Closing Bell to discuss.
Benefits brokerage, Nava Benefits, raised $40 million in a Series B round. Nava says it's on a mission to fix healthcare, one benefits plan at a time. The startup is working to bring benefits to small business that are normally available to only Fortune 500 companies. Brandon Weber, Co-Founder and CEO of Nava Benefits, joined Cheddar News' Closing Bell to discuss.
